Croatian Igor Stagljar Reveals Lung Cancer Drug Now Ready

Igor Stagljar

Croatian-Canadian molecular biologist Igor Stagljar, who is one of the world leaders in the field of proteomics and systems biology, said on HRT television 2nd January 2018 that a revolutionary lung cancer treatment he has been working on is now ready to be used. (Source HRT, Croatia Week)

Stagljar, who is a Professor of Molecular Genetics and Biochemistry at Donnelly Centre at the Medical School of the University of Toronto and co-founder of Dualsystems Biotech Inc, one of the world-leading companies in the field of interactive proteomics revealed on Croatian TV the readiness for the promising drug for use.

“We have come to the stage that the drug is ready for use and we will start applying it in Croatia as well, starting next year. We are cooperating with KBC Jordanovac (Clinic for Lung Diseases) in Zagreb and we will start final clinic research in Canada very soon, as well as in Croatia. It was my wish to complete the final clinical research in Croatia, my gift to the country I was born in”, Stagljar said on HRT show “U svom filmu” (In my film).

Stagljar has led a team of international scientists from the University of Toronto uncovering novel drug targets that might be used to rein lung cancers that have become resistant to available therapy for the past 8-10 years.

Four years ago Stagljar and his team discovered a new biomarker for lung cancer.

“This is a smart drug that selectively destroys tumour cells and leaves healthy cells intact,” Stagljar explained in 2014, saying then that his team was then on the verge of the final findings of the drug for lung cancer, the deadly disease which claimed more than 9 million people around the world last year.
Stagljar pointed out they may never find a way to beat tumours.

“Tumours are a disease of the past, the present, and the future. Maybe we’ll one day understand them at the molecular level, but we will never beat them. Tumours are very clever, they evolve. When we treat them with a given drug, they become resistant. We must always be prepared to have a battalion of new drugs that we will be able to produce after the mutations are discovered in patients. The whole tumour research is that we can treat them as chronic diseases for the next 20-30 years,” he said.

“Genes plays a small part in what causes cancers, only 9 percent. The remaining 91 percent comes from the environment. Forty percent of all cancers can be prevented by ourselves so we need to be careful about what we are eating and drinking, not exposing ourselves to infections of the virus and bacteria, and not to smoke”, he stressed.

Stagljar was born in Zagreb in 1966 and received a B.A. from the University of Zagreb before getting a Ph.D. in molecular biology from ETH Zurich in Switzerland. He then moved to Canada and has lived in Canada for more than 12 years.

Stagljar is probably best known for the development of the split-ubiquitin Membrane Yeast Two-Hybrid (MYTH) and Mammalian Membrane Two-Hybrid technologies, powerful tools for the identification of proteins associated with proteins that are localized to various cellular membranes.
This has led to many ground-breaking discoveries and the elucidation of functions of various membrane proteins involved in human health and disease. Ina Vukic

Comments

  1. Great news.

    Liked by 1 person

  2. This is fantastic news! Thank you for posting, Ina.

    Like

  3. Brilliant

    Like

  4. kolpa vat says:

    It would be great to see a collaboration with the Cleveland Clinic,now being headed by the esteemed Dr.Tomislav Mihaljvic

    Like

    • The clinical use of new drug is being planned to occur in US and Croatia as far as I am informed, so you could see that happen, kolpa vat… perhaps some lobbying wouldn’t go astray? 🙂

      Like

  5. Very wonderful and welcome news, Ina! Wow and I am happy to know your country discovered this and Igor Stagljar worked on this drug. 😀

    Like

  6. Robison Amelia says:

    Lung Cancer

    Like

Trackbacks

  1. […] via Croatian Igor Stagljar Reveals Lung Cancer Drug Now Ready — Croatia, the War, and the Future […]

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Disclaimer, Terms and Conditions:

All content on “Croatia, the War, and the Future” blog is for informational purposes only. “Croatia, the War, and the Future” blog is not responsible for and expressly disclaims all liability for the interpretations and subsequent reactions of visitors or commenters either to this site or its associate Twitter account, @IVukic or its Facebook account. Comments on this website are the sole responsibility of their writers and the writer will take full responsibility, liability, and blame for any libel or litigation that results from something written in or as a direct result of something written in a comment. The nature of information provided on this website may be transitional and, therefore, accuracy, completeness, veracity, honesty, exactitude, factuality and politeness of comments are not guaranteed. This blog may contain hypertext links to other websites or webpages. “Croatia, the War, and the Future” does not control or guarantee the accuracy, relevance, timeliness or completeness of information on any other website or webpage. We do not endorse or accept any responsibility for any views expressed or products or services offered on outside sites, or the organisations sponsoring those sites, or the safety of linking to those sites. Comment Policy: Everyone is welcome and encouraged to voice their opinion regardless of identity, politics, ideology, religion or agreement with the subject in posts or other commentators. Personal or other criticism is acceptable as long as it is justified by facts, arguments or discussions of key issues. Comments that include profanity, offensive language and insults will be moderated.
%d bloggers like this: